SciTransfer
Expertise area

Transnational health research funding coordination

5 European H2020 organizations list this as part of their work5 as their primary capability.

Top organizations

Most active in this area

  • INSTITUTO DE SALUD CARLOS III

    Spain's national health research institute and funding agency, coordinating transnational ERA-NET calls across biomedical and public health domains.

    Coordinator of ERA PerMed and EuroNanoMed III; participant in 16 ERA-NET Cofund projects spanning rare diseases (E-Rare-3), cancer (TRANSCAN-2), cardiovascular (ERA-CVD), and neurodegenerative diseases (NEURON Cofund).

    PrimaryES53 projects
  • MINISTERO DELLA SALUTE

    Italy's health ministry coordinating national research funding alignment with EU joint calls in cancer, rare diseases, precision medicine, and AMR.

    Fifteen ERA-NET Cofund projects (E-Rare-3, TRANSCAN-2/3, ERA-CVD, ERA PerMed, NEURON Cofund 1&2, etc.) form the backbone of their portfolio, all focused on aligning national funding with EU joint calls.

    PrimaryIT25 projects
  • MINISTRY OF HEALTH

    Israel's national health authority coordinating transnational research funding in rare diseases, AMR, neuroscience, and personalized medicine through ERA-NET mechanisms.

    Participated in 14 ERA-NET Cofund actions spanning cancer (TRANSCAN-2/3), cardiovascular (ERA-CVD), neuroscience (NEURON Cofund/2), personalized medicine (ERA PerMed), and rare diseases (E-Rare-3).

    PrimaryIL22 projects
  • CANADIAN INSTITUTES OF HEALTH RESEARCH

    Canada's federal health research funder, bridging Canadian and European research priorities through ERA-NET co-funding in rare diseases, AMR, cancer, and neurodegeneration.

    All 14 H2020 projects are ERA-NETs or coordination actions where CIHR acts as a co-funding agency aligning national and European research programmes.

    PrimaryCA14 projects
  • THE HEALTH RESEARCH BOARD

    Ireland's national health research funding agency, coordinating Irish participation in European transnational calls across rare diseases, cancer, neuroscience, and AMR.

    Participates in six ERA-NET Cofund and co-fund programmes (ERA PerMed, JPCOFUND2, NEURON Cofund2, JPIAMR-ACTION, TRANSCAN-3, EJP RD) as a national funding agency aligning Irish research with European calls.

    PrimaryIE10 projects